GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » Days Payable

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Days Payable : 308.66 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co Days Payable?

Nanjing Hicin Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥63.2 Mil. Nanjing Hicin Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥18.7 Mil. Hence, Nanjing Hicin Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 308.66.

The historical rank and industry rank for Nanjing Hicin Pharmaceutical Co's Days Payable or its related term are showing as below:

SZSE:300584' s Days Payable Range Over the Past 10 Years
Min: 58.82   Med: 105.71   Max: 257.41
Current: 257.41

During the past 12 years, Nanjing Hicin Pharmaceutical Co's highest Days Payable was 257.41. The lowest was 58.82. And the median was 105.71.

SZSE:300584's Days Payable is ranked better than
87.36% of 973 companies
in the Drug Manufacturers industry
Industry Median: 89.33 vs SZSE:300584: 257.41

Nanjing Hicin Pharmaceutical Co's Days Payable increased from Mar. 2023 (272.26) to Mar. 2024 (308.66). It may suggest that Nanjing Hicin Pharmaceutical Co delayed paying its suppliers.


Nanjing Hicin Pharmaceutical Co Days Payable Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co Days Payable Chart

Nanjing Hicin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.24 58.82 169.00 196.73 233.98

Nanjing Hicin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 272.26 254.24 271.94 223.64 308.66

Competitive Comparison of Nanjing Hicin Pharmaceutical Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing Hicin Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Hicin Pharmaceutical Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing Hicin Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Nanjing Hicin Pharmaceutical Co's Days Payable falls into.



Nanjing Hicin Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nanjing Hicin Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (59.895 + 63.948) / 2 ) / 96.594*365
=61.9215 / 96.594*365
=233.98

Nanjing Hicin Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (63.948 + 62.41) / 2 ) / 18.678*365 / 4
=63.179 / 18.678*365 / 4
=308.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Hicin Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Nanjing Hicin Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Hicin Pharmaceutical Co (SZSE:300584) Business Description

Traded in Other Exchanges
N/A
Address
Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009
Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.
Executives
Cao Yu Ping Directors, executives
Yan Mei Qiang Directors, executives
Jiang Xiang Ming Executives
Gu Hai Independent director

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Headlines

No Headlines